Safety Study of Apixaban in Recent Acute Coronary Syndrome

Overview[ - collapse ][ - ]

Purpose The purpose of this clinical research study is to determine whether apixaban will be safe in people who have recently had unstable angina or a heart attack.
ConditionAcute Coronary Syndrome (ACS)
InterventionDrug: Apixaban
Drug: Apixaban
Drug: Placebo
PhasePhase 2
SponsorBristol-Myers Squibb
Responsible PartyBristol-Myers Squibb
ClinicalTrials.gov IdentifierNCT00313300
First ReceivedApril 10, 2006
Last UpdatedSeptember 10, 2010
Last verifiedSeptember 2008

Tracking Information[ + expand ][ + ]

First Received DateApril 10, 2006
Last Updated DateSeptember 10, 2010
Start DateMay 2006
Estimated Primary Completion DateMay 2008
Current Primary Outcome MeasuresMajor and clinically relevant non-major bleeding [Time Frame: through end of treatment] [Designated as safety issue: Yes]
Current Secondary Outcome Measures
  • Composite of death, non-fatal myocardial infarction, severe recurrent ischemia and non-hemorrhagic stroke. [Time Frame: through end of treatment] [Designated as safety issue: No]
  • All bleeding events [Time Frame: through end of treatment] [Designated as safety issue: Yes]

Descriptive Information[ + expand ][ + ]

Brief TitleSafety Study of Apixaban in Recent Acute Coronary Syndrome
Official TitleA Phase 2, Placebo-Controlled, Randomized, Double Blind, Parallel Arm, Dose Ranging Study to Evaluate Safety and Efficacy of Apixaban in Patients With a Recent Acute Coronary Syndrome.
Brief Summary
The purpose of this clinical research study is to determine whether apixaban will be safe in
people who have recently had unstable angina or a heart attack.
Detailed DescriptionNot Provided
Study TypeInterventional
Study PhasePhase 2
Study DesignAllocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
ConditionAcute Coronary Syndrome (ACS)
InterventionDrug: Apixaban
Tablets, Oral, 2.5 mg, twice daily, 26 weeks
Drug: Apixaban
Tablets, Oral, 10 mg, once daily, 26 weeks
Drug: Placebo
Tablets, Oral, 0, twice daily, 26 weeks
Study Arm (s)
  • Active Comparator: A1
  • Experimental: A2
  • Placebo Comparator: A3

Recruitment Information[ + expand ][ + ]

Recruitment StatusCompleted
Estimated Enrollment1715
Estimated Completion DateMay 2008
Estimated Primary Completion DateMay 2008
Eligibility Criteria
Inclusion Criteria:

- Recent (< = 7 days) Acute Coronary Syndrome (ACS).

- Clinically stable on optimal treatment

Exclusion Criteria:

- High bleeding risk.

- Ongoing anticoagulant use.
GenderBoth
Ages18 Years
Accepts Healthy VolunteersNo
ContactsNot Provided
Location CountriesUnited States, Austria, Belgium, Canada, Denmark, France, Germany, Israel, Italy, Poland, Russian Federation, Spain, Sweden, United Kingdom

Administrative Information[ + expand ][ + ]

NCT Number NCT00313300
Other Study ID NumbersCV185-023
Has Data Monitoring CommitteeYes
Information Provided ByBristol-Myers Squibb
Study SponsorBristol-Myers Squibb
CollaboratorsNot Provided
Investigators Study Director: Bristol-Myers Squibb Bristol-Myers Squibb
Verification DateSeptember 2008

Locations[ + expand ][ + ]

Scottsdale Cardiovasular Research Institute
Scottsdale, Arizona, United States, 85251
Los Angeles County & University Of Southern Ca. Medical Cen.
Los Angeles, California, United States, 90033
Radiant Research,Santa Rosa
Santa Rosa, California, United States, 95405
South Denver Cardiology Associates
Littleton, Colorado, United States, 80120
Watson Clinic Center For Research
Lakeland, Florida, United States, 33805
Heart & Vasc Inst Of Fl
Safety Harbor, Florida, United States, 34695
Indian River Medical Center
Vero Beach, Florida, United States, 32960
Cardiac Disease Specialists, P.C.
Atlanta, Georgia, United States, 30309
Georgia Heart Specialists
Covington, Georgia, United States, 30014
Heartcare Midwest
Peoria, Illinois, United States, 61614
The Care Group, Llc.
Indianapolis, Indiana, United States, 46290
Iowa Heart Center
Des Moines, Iowa, United States, 50314
University Of Kentucky
Lexington, Kentucky, United States, 40536
William Beaumont Hospital-Troy
Troy, Michigan, United States, 48085
New York Cardiovascular Associates
New York, New York, United States, 10001
Unc Hospitals, Department Of Medicine
Chapel Hill, North Carolina, United States, 27599
Dumc
Durham, North Carolina, United States, 27705
Carolina Heart Specialists
Gastonia, North Carolina, United States, 28054
Piedmont Cardiology Associates
Hickory, North Carolina, United States, 28602
Wake Forest Univ Health Sciences
Winston-Salem, North Carolina, United States, 27157
Midwest Cardiology Research Foundation
Columbus, Ohio, United States, 43214
The Dayton Heart Center
Dayton, Ohio, United States, 45414
Oklahoma Cardiovascular Research Group
Oklahoma City, Oklahoma, United States, 73120
Geisinger Clinic - Cardiology
Danville, Pennsylvania, United States, 17822
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States, 17033
Rhode Island Hospital
Providence, Rhode Island, United States, 02903
Cardiovascular Associates, P.C
Kingsport, Tennessee, United States, 37660
University Of Texas Medical School - San Antonio
San Antonio, Texas, United States, 78229
Tyler Cardiovascular Consultants
Tyler, Texas, United States, 75701
Virginia Commonwealth University
Richmond, Virginia, United States, 23298
Local Institution
Feldkirch, Austria, 6800
Local Institution
Wien, Austria, 1160
Local Institution
Wien, Austria, 1090
Local Institution
Huy, Luik, Belgium, 4500
Local Institution
Aalst, Belgium, 9300
Local Institution
Antwerpen, Belgium, 2020
Local Institution
Brasschaat, Belgium, 2930
Local Institution
Brugge, Belgium, 8000
Local Institution
Brussels, Belgium, 1090
Local Institution
Genk, Belgium, 3600
Local Institution
Edmonton, Alberta, Canada, T5H 3V9
Local Institution
Edmonton, Alberta, Canada, T6K 4C1
Local Institution
Edmonton, Alberta, Canada, T6G 2B7
Local Institution
Victoria, British Columbia, Canada, V8R 4R2
Local Institution
St. John'S, Newfoundland and Labrador, Canada, A1B 3V6
Local Institution
Belleville, Ontario, Canada, K8N1E6
Local Institution
Chatham, Ontario, Canada, N7L 1B9
Local Institution
Hamilton, Ontario, Canada, L8L 2X2
Local Institution
London, Ontario, Canada, N6A 5A5
Local Institution
Oshawa, Ontario, Canada, L1H 1B9
Local Institution
Montreal, Quebec, Canada, H1T 2M4
Local Institution
Montreal, Quebec, Canada, H2X 3J4
Local Institution
Montreal, Quebec, Canada, H1T 1C8
Local Institution
St. Charles-Borromee, Quebec, Canada, J6E 6J2
Local Institution
Terrebonne, Quebec, Canada, J6V 2H2
Local Institution
Arhus C, Denmark, 8000
Local Institution
Copenhagen, Denmark, 2100
Local Institution
Esbjerg, Denmark, 6700
Local Institution
Frederiksberg, Denmark, 2000
Local Institution
Glostrup, Denmark, 2600
Local Institution
Hellerup, Denmark, 2900
Local Institution
Herning, Denmark, 7400
Local Institution
Randers, Denmark, DK-8900
Local Institution
Amiens Cedex 1, France, 80054
Local Institution
Cholet, France, 49300
Local Institution
Dijon, France, 21079
Local Institution
Nantes Cedex 01, France, 44093
Local Institution
Paris Cedex 13, France, 75651
Local Institution
Pessac Cedex, France, 33604
Local Institution
Roubaix Cedex 1, France, 59056
Local Institution
Toulouse, France, 31403
Local Institution
Berlin, Germany, 12351
Local Institution
Berlin, Germany, 12559
Local Institution
Duren, Germany, 52351
Local Institution
Halle / Saale, Germany, 06120
Local Institution
Hannover, Germany, 30625
Local Institution
Krefeld, Germany, 47805
Local Institution
Langen, Germany, 63225
Local Institution
Ludwigshafen, Germany, 67063
Local Institution
Witten, Germany, 58455
Local Institution
Afula, Israel, 18101
Local Institution
Hadera, Israel, 38100
Local Institution
Haifa, Israel, 34362
Local Institution
Haifa, Israel, 31096
Local Institution
Jerusalem, Israel, 91120
Local Institution
Jerusalem, Israel, 91031
Local Institution
Jerusalem, Israel, 91240
Local Institution
Kfar-Saba, Israel, 44281
Local Institution
Nazareth, Israel, 16100
Local Institution
Petach Tikva, Israel, 49100
Local Institution
Rehovot, Israel, 76100
Local Institution
Safed, Israel, 13100
Local Institution
Tel Aviv, Israel, 64239
Local Institution
Roma, Italy, 00168
Local Institution
Bialystok, Poland, 15-276
Local Institution
Bydgoszcz, Poland, 85-826
Local Institution
Bydgoszcz, Poland, 85-094
Local Institution
Bydgoszcz, Poland, 85-168
Local Institution
Cracow, Poland, 31-202
Local Institution
Gdansk, Poland, 80-952
Local Institution
Katowice, Poland, 40-635
Local Institution
Krakow, Poland, 31-501
Local Institution
Lodz, Poland, 91-347
Local Institution
Opole, Poland, 45-418
Local Institution
Torun, Poland, 87-100
Local Institution
Warszawa, Poland, 04-628
Local Institution
Zielona Gora, Poland, 65-046
Local Institution
Kemerovo, Russian Federation, 650002
Local Institution
Moscow, Russian Federation, 121552
Local Institution
Moscow, Russian Federation, 111020
Local Institution
Moscow, Russian Federation, 129327
Local Institution
Moscow, Russian Federation, 115487
Local Institution
Moscow, Russian Federation, 127473
Local Institution
Moscow, Russian Federation, 105229
Local Institution
Moscow, Russian Federation, 119620
Local Institution
Saint Petersburg, Russian Federation, 195067
Local Institution
Saint Petersburg, Russian Federation, 191104
Local Institution
Saint Petersburg, Russian Federation, 197110
Local Institution
Saint Petersburg, Russian Federation, 193312
Local Institution
Saratov, Russian Federation, 410028
Local Institution
St. Petersburg, Russian Federation, 194156
Local Institution
St.Petersburg, Russian Federation, 192242
Local Institution
Yaroslav, Russian Federation, 150062
Local Institution
Yaroslavl, Russian Federation, 150003
Local Institution
Baracaldo (Vizcaya), Spain, 48903
Local Institution
Barcelona, Spain, 08035
Local Institution
Hospitalet Llobregat Barcelona, Spain, 08907
Local Institution
Leon, Spain, 24071
Local Institution
Madrid, Spain, 28046
Local Institution
Malaga, Spain, 29010
Local Institution
Oviedo, Spain, 33006
Local Institution
Santiago De Compostela, Spain, 15706
Local Institution
Sevilla, Spain, 41071
Local Institution
Tarragona, Spain, 43007
Local Institution
Valladolid, Spain, 47010
Local Institution
Villajoyosa, Spain, 03570
Local Institution
Goteborg, Sweden, SE-416 85
Local Institution
Goteborg, Sweden, 413 45
Local Institution
Malmo, Sweden, 205 02
Local Institution
Orebro, Sweden, 701 85
Local Institution
Stockholm, Sweden, 141 86
Local Institution
Sundsvall, Sweden, 851 86
Local Institution
Uppsala, Sweden, 751 85
Local Institution
Stockport, Cheshire, United Kingdom, SK2 7JE
Local Institution
Harrow, Middlesex, United Kingdom, HA1 3UJ
Local Institution
Edinburgh, Midlothian, United Kingdom, EH16 4SB
Local Institution
Portadown, N. Ireland, United Kingdom, BT63 5QQ
Local Institution
Sheffield, South Yorkshire, United Kingdom, S10 2JF
Local Institution
York, Yorkshire, United Kingdom, YO31 8HE
Local Institution
Croydon, United Kingdom, CR7 7YE
Local Institution
Leicester, United Kingdom, LE3 9QP